Taxotere Class Action Lawsuit
Update: Dozens of Victims of Taxotere Side Effects File Suit in Cook County Circuit Court January 22, 2018 – A number of women who claim their hair fell out and never grew back due to a side effect of Taxotere...
Crux Vena Cava Filter Class Action Lawsuit
Overview The Crux Vena Cava Filter (VCF) is used for the prevention of pulmonary embolism (PE) in patients at risk for blood clots who are unable to take anticoagulant medications. The device consists of a self-expanding Nitinol filter that is...
OptEase IVC Filter Class Action Lawsuit
What is IVC Filter Placement? IVC filter placement involves placing a small filter in the patient’s inferior vena cava, a large abdominal vein that returns oxygen-depleted blood to the heart from the lower part of your body. The device is...
Tradjenta Class Action Lawsuit
Update: Diabetes Drugs Linked to Rhabdomyolysis December 1, 2017 – Tradjenta and other diabetes drugs in its class have been associated with a rare, life-threatening muscular disease called rhabdomyolysis, according to the FDA Adverse Event Reporting System (FAERS). Rhabdomyolysis occurs...
Jentadueto Class Action Lawsuit
FDA Investigating Link Between DPP-4 Inhibitors & Rhabdomyolysis December 1, 2017 – FDA has received reports of rhabdomyolysis, a syndrome caused by injury to skeletal muscle, in patients with type 2 diabetes who have taken Jantadueto and other DPP-4 inhibitors....
Kazano Class Action Lawsuit
Update: FDA Warning on Rhabdomyolysis Risk with Kazano December 1, 2017 – The U.S. Food & Drug Administration has recently obtained data indicating that Kazano and other DPP-4 inhibitors may increase the risk for rhabdomyolysis, a severe muscular disease characterized...
Oseni Class Action Lawsuit
Oseni lawsuits have been filed on behalf of diabetes patients who have suffered from side effects including pancreatic cancer, rhabdomyolysis, heart failure and more. If you or somebody you know has suffered side effects after using Oseni, you may be...
Nesina Class Action Lawsuit
Update: DPP-4 Inhibitors Linked to Severe Muscle-Wasting Condition December 1, 2017 – Nesina and other type 2 diabetes medicines from the DPP-4 class may increase a user’s risk of developing rhabdomyolysis, a condition that results from the death of muscle...
Bydureon Class Action Lawsuit
What is Bydureon? Approved in January 2012, Bydureon (exenatide injection) is a longer-lasting version of the Byetta pen. Exenatide belongs to a class of drugs called glucagonlike peptide-1 (GLP-1) receptor agonists that work by mimicking the effects of the body’s...